GlassScriptPhysician profile
Michael C Gravett
NPI 1417056490
$19,754.07
in general payments reported to CMS, 2019-2025
13 companies · $899 in 2025
The $899 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $10K · 2022: $6,265 · 2023: $1,648 · 2024: $795 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,342.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 4web, INC. | $18,068.97 | 2021-2025 | Spine Truss System |
| Stryker Corporation | $672.56 | 2023-2025 | N/A, Insignia, Es2 Spinal System |
| Globus Medical, INC. | $544.38 | 2021-2023 | Hedron Ia, Sable, Monument |
| Vertex Pharmaceuticals Incorporated | $136.05 | 2024-2025 | |
| Orthofix Medical, INC. | $100.00 | 2022 | |
| Intrinsic Therapeutics | $60.87 | 2025 | Barricaid Acd (Annular Closure Device) |
| Medtronic, INC. | $49.74 | 2025 | O-Arm |
| Nevro Corp. | $24.42 | 2024 | Senza |
| Collegium Pharmaceutical, INC. | $21.63 | 2024 | Belbuca |
| Bioventus LLC | $21.61 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Abbvie INC. | $21.40 | 2025 | |
| Avanos Medical | $18.72 | 2025 | Standard Rf Disposables |
| Curonix LLC | $13.72 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gravett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.